Gabapentin Tablet, Coated
Product Images NDC 68071-3783

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68071-3783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3783 9)

This text appears to be a detailed medication label containing information about Gabapentin 600mg tablets. It provides details such as the National Drug Code (NDC), lot numbers, expiration date, manufacturer details, quantity, and dosage information. It also includes warnings about keeping the medication out of reach of children and storing it at a controlled temperature. Additionally, it encourages individuals to contact their doctor for medical advice regarding any potential side effects and provides information for reporting side effects to the FDA.*

FDA Label Image

Chemical Structure (Gabapentin 01)

FDA Label Image

Figure 1 (Gabapentin 02)

This text provides information on the mean pain scores during a study comparing a 4-week dose titration period with a 4-week fixed dose period. The study compares the effects of placebo versus Gabapentin at a dosage of 3,600 mg/day on pain scores. The data is structured in columns representing different time points from baseline to the end of the study.*

FDA Label Image

Figure 2 (Gabapentin 03)

This text seems to be displaying a clinical trial layout. The study involves a 3-week dose titration period followed by a 4-week fixed dose period involving two different dosages of gabapentin - 1,800 mg/day and 2,400 mg/day. The study is measuring the mean pain score at different time points (Baseline, 1, 2, 3, 4, 5, 6, and T).*

FDA Label Image

Figure 3 (Gabapentin 04)

This text appears to be a statistical representation, possibly related to percentages and studies. It includes data points such as 100%, 90%, 80%, etc., along with study numbers labeled as Study 1 and Study 2. Additionally, there are mentions of treatments or conditions denoted as PBO and GBP with corresponding values like 1800 and 2,400.*

FDA Label Image

Figure 4 (Gabapentin 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.